A 12-week parallel group, randomized, placebo-controlled, double-blinded, multi-center study to evaluate efficacy and safety of 2 concentrations of SAF312 eye drops (5 mg/ml and 15 mg/ml) used twice-daily in the treatment of postoperative corneal

Administered By

Awarded By

Contributors

Start/End

  • July 22, 2021 - October 13, 2023